Dr. Ben Rutter

Dr. Ben Rutter is a seasoned professional in the fields of communications and biotechnology, currently serving as a Senior Account Manager at Zyme Communications Ltd since July 2020. Previous experiences include roles as a COVID-19 Test Site Operative with the Department of Health and Social Care for a brief period in June 2020, and as a Trainee Patent Attorney at Marks & Clerk from October 2018 to April 2020, where responsibilities involved patent application drafting for biotechnology firms. Dr. Rutter obtained a Ph.D. in Microbiology from the University of Aberdeen, where significant research was conducted on the biosynthesis of Myriocin. Additional academic qualifications include a Bachelor's degree in Genetics from the same institution and A levels in Biology, Chemistry, Maths, and German from Haberdashers' Adams.